Reversal of pulmonary hypertension associated with plexiform lesions in congenital heart disease: A case report

被引:12
作者
Epting, CL
Wolfe, RR
Abman, SH
Deutsch, GH
Ivy, D
机构
[1] Childrens Hosp, Pediat Heart Lung Ctr, Pediat Cardiol Sect, Denver, CO 80218 USA
[2] Childrens Hosp, Pediat Heart Lung Ctr, Sect Pulmonol, Denver, CO 80218 USA
[3] Childrens Hosp, Pediat Heart Lung Ctr, Sect Pathol, Denver, CO 80218 USA
关键词
pulmonary hypertension; congenital heart disease; nitric oxide; atrial natriuretic peptide; patent ductus arteriosus;
D O I
10.1007/s00246-001-0044-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a 2-year-old child with severe pulmonary hypertension due to a patent ductus arteriosus (PDA) with plexiform lesions on lung biopsy. Despite high basal pulmonary vascular resistance with minimal responsiveness to inhaled nitric oxide and other vasodilators, and advanced plexogenic arteriopathy on lung biopsy, her pulmonary hypertension completely resolved after PDA ligation and during 8 years of follow-up.
引用
收藏
页码:182 / 185
页数:4
相关论文
共 50 条
  • [31] Acquired Cardiovascular Diseases in Patients with Pulmonary Hypertension Due to Congenital Heart Disease: A Case Report
    Ereminiene, Egle
    Stuoka, Mantvydas
    Ordiene, Rasa
    Plisiene, Jurgita
    Miliauskas, Skaidrius
    Tamulenaite, Egle
    MEDICINA-LITHUANIA, 2024, 60 (02):
  • [32] Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Mahmoud, Ahmed K.
    Abbas, Mohammed Tiseer
    Kamel, Moaz A.
    Farina, Juan M.
    Pereyra, Milagros
    Scalia, Isabel G.
    Barry, Timothy
    Chao, Chieh-Ju
    Marcotte, Francois
    Ayoub, Chadi
    Scott, Robert L.
    Majdalany, David S.
    Arsanjani, Reza
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01):
  • [33] Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directions
    Gatzoulis, Michael A.
    Beghetti, Maurice
    Landzberg, Michael J.
    Galie, Nazzareno
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (02) : 340 - 347
  • [34] Contemporary use of Selexipag in pulmonary arterial hypertension associated with congenital heart disease: a case series
    Blissett, Sarah
    Blusztein, David
    Mahadevan, Vaikom S.
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2020, 4 (06)
  • [35] Respiratory Microbiome Profile of Pediatric Pulmonary Hypertension Patients Associated With Congenital Heart Disease
    Wang, Ting
    Xing, Yue
    Peng, Bingming
    Yang, Kai
    Zhang, Chenting
    Chen, Yuqin
    Geng, Gang
    Li, Qubei
    Fu, Jian
    Li, Mi
    Luo, Zhengxiu
    Fu, Zhou
    Wang, Jian
    HYPERTENSION, 2023, 80 (01) : 214 - 226
  • [36] Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension
    Mese, Timur
    Guven, Baris
    Yilmazer, Murat Muhtar
    Karadeniz, Cem
    Ozdemir, Rahmi
    Doksoz, Onder
    CONGENITAL HEART DISEASE, 2018, 13 (04) : 506 - 511
  • [37] Plasma copeptin levels in children with pulmonary arterial hypertension associated with congenital heart disease
    Reem Gaheen
    Doaa El Amrousy
    Hossam Hodeib
    Shimaa Elnemr
    European Journal of Pediatrics, 2021, 180 : 2889 - 2895
  • [38] Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease
    Yu, Xue
    Zhang, Yi
    Luo, Qin
    Liu, Zhihong
    Zhao, Zhihui
    Zhao, Qing
    Gao, Liu
    Jin, Qi
    Yan, Lu
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2018, 52 (06) : 378 - 382
  • [39] The Challenges in Managing Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Lu, Chun-Wei
    ACTA CARDIOLOGICA SINICA, 2015, 31 (06) : 516 - 517
  • [40] Plasma copeptin levels in children with pulmonary arterial hypertension associated with congenital heart disease
    Gaheen, Reem
    El Amrousy, Doaa
    Hodeib, Hossam
    Elnemr, Shimaa
    EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (09) : 2889 - 2895